🇺🇸 FDA
Patent

US 8809542

Salts of benzimidazole compound and use thereof

granted A61KA61K31/4439A61P

Quick answer

US patent 8809542 (Salts of benzimidazole compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/4439, A61P, A61P1/04, A61P25/20